Person:
ONUR, AHMET RAHMİ

Loading...
Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

Organizational Unit

Job Title

Last Name

ONUR

First Name

AHMET RAHMİ

Name

Search Results

Now showing 1 - 9 of 9
  • Publication
    The effect of using a standard Illustrated consent form on anxiety levels in the urodynamic investigation: A prospective clinical study
    (2022-09-07) ŞAHİN, BAHADIR; ŞEKERCİ, ÇAĞRI AKIN; ONUR, AHMET RAHMİ; ÇAM, HAYDAR KAMİL; TARCAN, TUFAN; Özkan O., Güçtaş A. Ö. , Şahin B., Şekerci Ç. A. , Onur A. R. , Çam H. K. , Tarcan T.
  • Publication
    The Role of Educational Level and Cognitive Status in Men Undergoing Artificial Urinary Sphincter Implantation REPLY
    (ELSEVIER SCIENCE INC, 2021) ONUR, AHMET RAHMİ; Keles, Ahmet; Onur, Rahmi; Aydos, Murat; Dincer, Murat; Koca, Orhan; Coskun, Burhan; Imamoglu, Abdurrahim; Karakeci, Ahmet
  • Publication
    Ürodi̇nami̇ işlemi̇nde standart şeki̇lli̇ bi̇r form ile hasta bi̇lgi̇lendi̇ri̇lmesi̇ni̇n kaygı düzeyleri̇ne etki̇si̇: Prospekti̇f kli̇ni̇k çalışma
    (2022-11-13) ŞAHİN, BAHADIR; ŞEKERCİ, ÇAĞRI AKIN; ONUR, AHMET RAHMİ; ÇAM, HAYDAR KAMİL; TARCAN, TUFAN; ÖZKAN O. C., Güçtaş A. Ö., ŞAHİN B., ŞEKERCİ Ç. A., ONUR A. R., ÇAM H. K., TARCAN T.
  • Publication
    Ürodinami işleminde standart şekilli bir form ile hasta bilgilendirilmesinin kaygı düzeylerine etkisi: prospektif klinik çalışma
    (2022-11-09) ŞAHİN, BAHADIR; ŞEKERCİ, ÇAĞRI AKIN; ONUR, AHMET RAHMİ; ÇAM, HAYDAR KAMİL; TARCAN, TUFAN; Özkan O. C. , Güçtaş A. Ö. , Şahin B., Şekerci Ç. A. , Onur A. R. , Çam H. K. , Tarcan T.
  • Publication
    Effect of focal and diffuse hypervascularization as cystoscopic findings on predicting intravesical therapy response in patients with bladder pain syndrome
    (AVES, 2021) ONUR, AHMET RAHMİ; Erol, Bulent; Kazan, Huseyin Ozgur; Keser, Ferhat; Efiloglu, Ozgur; Danacioglu, Yavuz Onur; Onur, Rahmi
    Objective: To define the relationship between cystoscopic findings, including novel findings such as the hypervascularization, of bladder pain syndrome/interstitial cystitis (BPS/IC) and the response to intravesical therapy. Material and methods: We retrospectively evaluated cystoscopy findings in patients who had a preliminary diagnosis of BPS/IC. All patients received early intravesical combined therapy (ICT), ie, within 2 hours after hydrodistention. Additionally, ICT was continued according to our protocol. Cystoscopic findings were classified as glomerulations, hypervascularization, and Hunner's lesion (HL). The therapy responses were evaluated at 1st, 3rd, 6th, and 12thmonths using the visual analog scale (VAS), O'Leary/Sant interstitial cystitis symptom index (ICSI), and interstitial cystitis problem index (ICPI) scores. Results: Out of 61 patients, HL was diagnosed during cystoscopy in six (9.8%) patients, glomerulations in 35 (57.4%) patients, and hypervascularization in 15 (24.6%) patients. No pathological findings were defined in five (8.2%) patients. In the glomerulation and hypervascularization group, the median VAS, ICSI, and ICPI scores were lower than those in the preoperative period in the follow-up. In patients with HL, the median VAS scores were lower in the entire follow-up compared to the preoperative period, with an increase at 1st year compared to 6th month, and ICSI scores were lower than preoperative period in the entire follow-up, with an increase at 3rd month and 1st year. ICPI scores were also lower during the follow-up, with an increase observed in the 1st year. Conclusion: The presence of hypervascularization should be defined since it might show different characteristics that may affect the ICT response. Patients with glomerulations might be good candidates for early combined intravesical therapy.
  • Publication
    The International Continence Society (ICS) report on the terminology for male lower urinary tract surgery
    (WILEY, 2020) ONUR, AHMET RAHMİ; Abranches-Monteiro, Luis; Hamid, Rizwan; D'Ancona, Carlos; Alhasso, Ammar; Dmochowski, Roger; Ecclestone, Hazel; Haylen, Bernard; Mousa, Riyad Al; Onur, Rahmi; Shah, Shahzad; Vasudeva, Pawan; Oelke, Matthias
    Introduction In the development of terminology of the lower urinary tract (LUT), due to its increasing complexity, the terminology for male LUT surgery needs to be updated using a male-specific approach and via a clinically-based consensus report. Methods This report combines the input of members of the Standardization Committee of the International Continence Society in a Working Group with recognized experts in the field, assisted by many external referees. Appropriate core clinical categories and a subclassification were developed to give a numeric coding to each definition. An extensive process of 14 rounds of internal and external review was developed to exhaustively examine each definition, with decision-making by collective opinion (consensus). Results A Terminology Report for male LUT and pelvic floor surgery, encompassing 149 separate definitions/descriptors, has been developed. It is clinically-based with the most common diagnoses defined. Clarity and user-friendliness have been key aims to make it interpretable by practitioners and trainees in male LUT surgery. Figures have not been included to avoid any preference or bias towards a specific procedure. Conclusions A consensus-based Terminology Report for male LUT surgery has been produced aimed at being a significant aid to clinical practice and a stimulus for research.
  • Publication
    Efficacy and safety of onabotulinumtoxinA injection in patients with refractory overactive bladder: First multicentric study in Turkish population
    (WILEY, 2018) ONUR, AHMET RAHMİ; Onem, Kadir; Bayrak, Omer; Demirtas, Abdullah; Coskun, Burhan; Dincer, Murat; Kocak, Izzet; Onur, Rahmi
    AimsTo investigate the efficacy and safety of intradetrusor onabotulinumtoxinA (onaBoNT-A) injection in patients with overactive bladder (OAB) refractory to antimuscarinic treatment. MethodsA total of 80 patients with OAB symptoms were enrolled in this prospective multicenter study and received 100U intradetrusor onaBoNT-A injection.The changes from baseline in the frequency of voiding, urge urinary incontinence (UI) and urge episodes, mean and maximum bladder capacities, uroflowmetry, post-void residual urine volume (PVR), quality of life score, and treatment benefit scale score were assessed. The need for a second injection,and treatment-related adverse events were also examined postoperatively. ResultsOnaBoNT-A injection significantly decreased the UI episodes(P=0.0001), the mean voiding frequency (P=0.0001), and the urgency episodes (P=0.0001) in the third month compared to baseline. Similarly, the mean bladder capacity, and maximal bladder capacity were increased (P<0,05). The quality of life scores improved by 57.1% compared to the pre-treatment rate (P=0,0001). No significant change was observed in the PVR or maximum flow rate. Urinary retention developed in 3 (3.75%) patients and urinary infection and transient hematuria were observed in five patients (6.25%) each. The UI episodes, voiding frequency and urgency episodes were significantly lower at the 9th month than at baseline (all P=0.0001). Overall 67% of the patients continued to experience benefits from the injection. Sixteen patients (20%) required a second injection in the third month. Eight patients were lost to follow-up at the last visit in the 9th month, and 34 of the remaining 56 patients required a second injection at the 9th month. Cumulatively, 50 (63%) patients needed re-injections. ConclusionsOur results demonstrated that the onaBoNT-A injection produced significant improvement in all OAB symptoms with a low incidence of treatment related adverse events.
  • Publication
    The Role of Educational Level and Cognitive Status in Men Undergoing Artificial Urinary Sphincter Implantation
    (ELSEVIER SCIENCE INC, 2021) ONUR, AHMET RAHMİ; Keles, Ahmet; Onur, Rahmi; Aydos, Murat; Dincer, Murat; Koca, Orhan; Coskun, Burhan; Imamoglu, Abdurrahim; Karakeci, Ahmet
    OBJECTIVE To examine the relationship between education level, cognitive function of patients and the success/ revision rates of artificial urinary sphincter (AUS) implantation in men with postprostatectomy incontinence. METHODS Between January 2010 and March 2018, 163 patients (mean age, 68 +/- 6.8 years) with moderate-to-severe stress urinary incontinence who underwent AUS implantation were retrospectively examined. Demographic data, body mass index, comorbidities, surgical technique, previous strictures, and radiation therapy were recorded. Incontinence was measured by daily pad use and evaluated by International Consultation on Incontinence Questionnaire-short form. Patients' overall improvement was assessed using the Patient Global Impression of Improvement questionnaire. Education level was determined using the International Standard Classification of Education. Cognitive status was assessed using the Mini-Mental State Examination. Treatment success was defined as the need for <= 1 pad/day at last follow-up. RESULTS AUS was successful in 77.3% of patients. The International Consultation on Incontinence Questionnaire-short form score improved significantly from 19.9 +/- 2.9 to 4.4 +/- 5.4 (P = .001). The median outcome reported subjectively on the Patient Global Impression of Improvement scale was 2.1 +/- 1.5 (1-7) and self-reported as much better. Patients' education level had statistically no significant relationship with AUS success and revision rates. Similarly, there was no significant relationship between cognitive status, educational level and the need for revision of AUS (P >.05). However, patients with moderate cognitive impairment and a body mass index >30 showed significantly lower AUS success rates (P <.05). CONCLUSION AUS implantation is safe and effective treatment option especially for nonobese and cognitively intact patients of all educational levels. (C) 2020 Elsevier Inc.
  • Publication
    Prevalence of female urinary incontinence in the developing world: A systematic review and meta-analysis-A Report from the Developing World Committee of the International Continence Society and Iranian Research Center for Evidence Based Medicine
    (WILEY, 2020) ONUR, AHMET RAHMİ; Mostafaei, Hadi; Sadeghi-Bazargani, Homayoun; Hajebrahimi, Sakineh; Salehi-Pourmehr, Hanieh; Ghojazadeh, Morteza; Onur, Rahmi; Al Mousa, Riyad T.; Oelke, Matthias
    Aims The prevalence of urinary incontinence (UI) in the developing world varies widely. Factors influencing prevalence rates are a key area of interest, and knowledge of these would provide appropriate planning for preventive primary and secondary health care programs. The objective of this report was to synthesize the best available evidence to determine UI prevalence rates in adult women in a population setting. Methods A comprehensive search strategy was employed to find published and unpublished studies. Databases searched included PubMed, Embase, Scopus, Web of Science, and Google Scholar. We used the standardized Joanna Briggs Institute Meta-Analysis of Statistics, Assessment, and Review Instrument to appraise the included studies. Results In total, 54 studies with 138,722 women aged 10 to 90 years were included in this meta-analysis. Prevalence of UI ranged from 2.8% in Nigeria to 57.7% in Iran. The total prevalence of UI was 25.7% (95% CI: 22.3-29.5) and the prevalence rates for stress, urgency, and mixed UI were 12.6% (95% CI: 10.3-15.4), 5.3% (95% CI: 3.4-8.3), and 9.1% (95% CI: 7.0-11.8), respectively. When we excluded the elderly population, UI prevalence only slightly changed (26.2%; 95% CI: 22.6-30.2). Prevalence rates varied considerably during different recall periods, ranging from 15.6% for UI during the last 12 months to 41.2% for UI during the last 3 months. However, the study quality and use of validated vs nonvalidated questionnaires only had a minor impact on the prevalence rates. Conclusions The prevalence, methodology, and definition of UI vary widely. A large-scale multinational study with a homogeneous methodology is necessary to correctly calculate and compare the prevalence rates to improve health policies in the developing world.